Civitas Resources CIVI 深 沪
已收盘 10-10 16:00:00 美东时间
29.48
-3.460
-10.50%
华盛通- 最 高32.36
- 今 开32.22
- 成交量 299.80万股
- 最 低 29.415
- 昨 收 32.94
- 总市值 27.32亿
- 52周最高 53.85
- 市盈率 静 3.49
- 换手率 3.24%
- 52周最低 21.79
- 委 比 64.44%
- 总股本 9266.00万
- 历史最高 76.778
- 量 比 1.27
- 振 幅 8.94%
- 历史最低 21.79
- 每 手 1
- 风险率 8.96%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shares of oil and gas companies are trading lower following reports of a ceasefire commencing in the Gaza Strip.
Shares of oil and gas companies are trading lower following reports of a ceasef...
10-11 00:30
Civitas evaluating merger with rival SM Energy - report
Civitas Resources (NYSE:CIVI) is evaluating a merger with Permian Basin rival SM Energy (NYSE:SM). Civitas (NYSE:CIVI) has been in talks with SM Energy (NYSE:SM) about a transaction that wouldn't inc...
10-09 22:45
美股大行评级 | 最高300美元，AMD获多家大行上调目标价！
今日重点评级关注：Maxim Group：维持Gain Therapeutics"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Icecure Medical"买入"评级，目标价从2美元升至2.5美元
10-08 09:14
'Permian Explorer Civitas Said to Explore Potential Sale' -Bloomberg
https://www.bloomberg.com/news/articles/2025-09-30/permian-explorer-civitas-said-to-explore-potential-sale
10-01 03:58
Civitas Resources jumps on report it's exploring a possible sale
Civitas Resources (NYSE:CIVI) gained 2.2% on a report that the oil and gas explorer is exploring a sale. Civitas, which is working with advisers, is evaluating a deal with similarly sized or larger co...
10-01 03:55
美股大行评级 | 潜在涨幅485.44%！Allarity Therapeutics获机构升目标价至9.25美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从9美元升至9.25美元；JMP证券：维持Crinetics Pharmaceuticals"跑赢大市"评级，目标价从86美元升至143美元
09-29 09:15
Morgan Stanley Downgrades Civitas Resources to Equal-Weight, Maintains Price Target to $40
Morgan Stanley analyst Devin McDermott downgrades Civitas Resources (NYSE: CIVI) from Overweight to Equal-Weight and maintains the price target from $40 to $40.
09-26 20:03
Apartment Investment declares $2.23 special dividend
Apartment Investment (NYSE:AIV) declares $2.23/share special dividend. Payable Oct. 15; for shareholders of record Sept. 30; ex-div Sept. 30. See AIV Dividend Scorecard, Yield Chart, & Dividend Growth...
09-16 12:44
美股大行评级 | 潜在涨幅432.99%！维持"投机性买入"评级，Unicycive Therapeutics获机构升目标价至21美元
今日重点评级关注：Benchmark：维持Unicycive Therapeutics"投机性买入"评级，目标价从3美元升至21美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从17美元升至25美元
09-16 09:48
What Analysts Are Saying About Civitas Resources Stock
During the last three months, 6 analysts shared their evaluations of Civitas Re...
09-16 03:01
